Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$80.80 USD
+0.06 (0.07%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $80.77 -0.03 (-0.04%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth A Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Inspire Medical Systems, Inc. has a PEG ratio of 1.21 compared to the Medical Info Systems industry's PEG ratio of 3.35.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INSP 80.80 +0.06(0.07%)
Will INSP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSP
Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report?
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics
Other News for INSP
The technical outlook for INSP is unchanged after it rises 0.86% on September 15
Nyxoah files patent infringement lawsuit against Inspire Medical
Nyxoah files patent infringement lawsuit against Inspire Medical
Is INSP preparing to trend lower? 180 Bearish Setup shows up after dropping 3.32%
The technical outlook for INSP is unchanged after it rises 5.12% on September 11